Literature DB >> 16623012

The prevalence and risk factors of osteoporosis in Thai renal-transplant patients.

North Techawathanawanna1, Yingyos Avihingsanon, Kerkiat Praditpornsilpa, Kannaungnit Kingpetch, Sompong Suwanwalaikorn, Talemgsak Kanjanabuch, Somchai Eiam-Ong, Kriang Tungsanga.   

Abstract

OBJECTIVES: To determine the prevalence and risk factors of osteoporosis after renal transplantation in Thai patients. MATERIAL AND
METHOD: A single-center cross-sectional study of bone mineral density was conducted in 102 Thai renal allograft recipients. Correlations were made between the clinical parameters and the occurrences of osteoporosis.
RESULTS: The prevalence of osteoporosis was 24.5%, 9.8% and 26.4% at lumbar vertebrae, hip region, and any sites, respectively. Binary logistic regression analysis revealed that cumulative dosage of steroids was significantly correlated with osteoporosis of the lumbar spine (p = 0.023, adjusted OR = 1.005), while body mass index (p = 0.005, adjusted OR = 0.738) and age (p = 0.052, adjusted OR = 1.077) were correlated with osteoporosis of the hip region.
CONCLUSION: Osteoporosis is common in Thai renal allograft recipients, particularly of the lumbar vertebrae. Cumulative dosage of steroids is the most important risk factor of low BMD of the lumbar vertebrae.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16623012

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Clinical predictors of incipient vertebral fractures and bone mineral density in kidney transplant patients.

Authors:  Dilek Gogas Yavuz; Kadriye Aydin; Tugce Apaydin; Arzu Velioglu; Meral Mert; Zafer Pekkolay; Ergun Parmaksiz; Meral Mese; Ayse Esen Pazir; Emre Aydın; Onur Bugdayci; Serhan Tuglular
Journal:  Eur Spine J       Date:  2022-04-04       Impact factor: 2.721

Review 2.  Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Authors:  Gong-bin Lan; Xu-biao Xie; Long-kai Peng; Lei Liu; Lei Song; He-long Dai
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.